An interventional study of Heat exposure in Lactation, sponsored by Providence College. Recruiting at 1 site in United States. Open to female participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-06-25.
Sponsored by Providence College · Not applicable, Interventional, and Other
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 251 studies in Breast Feeding with a site in United States — 43 open to participants now, 49 under way, none of them phase 3. Breast Feeding · United States.
Among the 251 studies in Breast Feeding with a site in United States, this one is the 174th largest by planned enrollment of the 202 interventional ones that give a count, is one of 16 that started in 2025, is one of 164 with no phase, reaches primary completion later than 8 of the 48 other live ones, and was the 234th registered.
1,083 studies on the registry are indexed under Breast Feeding; 216 are open to participants now.
Browse Breast Feeding studies →43 of the 251 studies in Breast Feeding with a site in United States are open now. Recruiting first, the newest first:
The University of Texas Health Science Center, Houston · Sites in United States
Ages 18+ · Women only
University of Illinois at Urbana-Champaign · Sites in United States
Ages 21–45 · Women only · Healthy volunteers
Eli Lilly and Company · Sites in United States, Canada, Denmark and 4 more countries
Ages 3 wk+ · Women only
University of Alabama at Birmingham · Sites in United States
Ages 18–50 · Women only
University of Colorado, Denver · Sites in United States
Women only · Healthy volunteers
A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →
Of the 125 Breast Feeding studies recruiting now, 65 (52%) set no upper age limit and 58 (46%) stop at 75 or younger; 52 take children under 18; 75 take healthy volunteers.
This study: 18 Years to 45 Years · female · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
251 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 10 · Phase 2 10 · Phase 3 6 · Phase 4 14
First in 2000; this study’s year is marked. 16 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 10 is below the median of 100 across 846 interventional studies indexed under Breast Feeding.
Median enrollment 83 across the 202 interventional studies, 88 across the 49 observational. Of the 180 that completed or were terminated, 47 (26%) have results posted.
This tab as a report to print or save as PDF → With an account.
22 of 251 have an industry lead sponsor. The 10 most frequent:
Providence College is the lead sponsor of 4 studies on the registry; 2 are open to participants now.
Providence College has 1 study filed under Breast Feeding — fewer than ten, so there is no comparison to draw.
15 of the studies in Breast Feeding with a site in United States that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07176793University of California, DavisPregnancy and Postpartum Breastfeeding Support for Patients With Gestational Diabetes | 2026-12-30 |
| NCT05457972University Hospitals Cleveland Medical CenterPostpartum Vaginal Estrogen for Breastfeeding Patients | 2026-12-31 |
| NCT06107933Johns Hopkins Bloomberg School of Public HealthDevelopmental Impacts of Microplastics Exposure in Early Life | 2026-12-31 |
| NCT05441709Endeavor HealthFurthering Equity Through Infant Feeding EDucation and Support | 2026-12-31 |
| NCT03838536University of North Carolina, Chapel HillSynergistic Activity of Human Milk Nutrients and Infant Cognition | 2027-03 |
Add all 15 to your calendar (.ics) → With an account.
Among the 251 studies in Breast Feeding with a site in United States, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This clinical trial aims to determine whether heat stress alters 24-hour breast milk production and composition following an acute bout of exercise in the heat among lactating women.
The main questions are:
Participants will complete the following visits: 1) initial consent visit 2) baseline testing; 3) acute exercise in the hot condition (HOT; 36C, 40% relative humidity), and 4) acute exercise in the temperate, thermoneutral condition (TEMP; 20C, 20% relative humidity). The baseline testing day will measure participant anthropometrics including height, weight, and body composition measured by a DEXA scan. For both experimental trials, participants will be asked to walk on a treadmill at based on their metabolic heat production (8W/kg) for 60 minutes. Heart rate (HR), mean skin temperature (Tsk), core temperature (Tcore), sweat loss (SL), and fluid intake will be measured throughout the exercise protocol. Breast milk composition will be measured through milk expression using a manual expression breast pump immediately and 24 hours post-exercise. Participants will log their breast milk production for 24 hours following the exercise using an infant scale to measure their infants before and after each feed.
This study will be a randomized, cross-over design with four study visits: 1) an initial visit where the participant can see the study equipment, ask questions, and fill out a brief questionnaire to determine whether they are eligible to participant; 2) baseline and metabolic heat production testing; 3) acute exercise in the hot condition [experimental trial 1 (HOT): 36C, 40% relative humidity], and 4) acute exercise in the temperate, thermoneutral condition [experimental trial 2 (TEMP): 20C, 20% relative humidity]. Data collection will occur at the Health and Human Performance Laboratory (HHPL) in the Department of Health Sciences.
Visit 1: Initial Visit The participant will come to the lab for an initial visit. During this brief visit (\<30 min), the participant can ask questions about the study, see the study equipment, and will be asked to complete a questionnaire to determine their eligibility.
Visit 2 (Baseline and Metabolic Heat Production Testing):
The baseline testing will collect participant anthropometric data, which includes height, body mass, and body composition (dual-energy X-ray absorptiometry, DXA) scan and a stepwise metabolic heat production test. Participants will report to the laboratory having abstained from caffeine, alcohol, and food (12, 24, and 4 hours, respectively). Upon arrival, participants will provide a small urine sample in a sterile urine cup to measure hydration status and for a pregnancy test. Researchers will measure hydration status using a refractometer. If the pregnancy test is positive, the PI will inform the participant that the test is positive and will not perform the scan. The participant will also no longer be eligible to continue with the study. After hydration assessment, nude body mass and height will be collected and the participant's body composition will measured using DXA. To obtain a nude body mass, a private curtain-changing area with a body weight scale will be provided to ensure privacy. Only the participant will be able to enter. The scale reading will come outside the private curtain area for the researchers to see. The DXA software will generate lean mass, fat mass, and body fat percentage. To calculate exercise intensity based on a fixed metabolic heat production (per unit body mass), participants will undergo a 24-min incremental treadmill test in an environmental chamber. Participants will perform the test in the same environmental conditions as the HOT trial (36C, 40% relative humidity; described below). Participants will don a heart rate (HR) monitor before testing. The treadmill test will consist of 6 x 4-min stages and progressively increase speed (2.5mph, 3.0mph, 3.5mph, 4.0mph, 4.5mph, and 5.0mph). The treadmill grade will be set at 2% to account for terrain and wind resistance. Oxygen consumption and respiratory exchange were collected continuously (30-sec average) using a Hans Rudolph metabolic mask (Hans Rudolph Inc., Shawnee, KS, USA) attached to a hose and delivered to the metabolic cart system (Parvo Medics Truemax 2400 Metabolic Measurement System, Consentius Technologies, Sandy, UT). These variables will be used to calculate metabolic heat production using partitional calorimetry (Cramer \& Jay, 2019). An exercise intensity of 8 W/kg was selected to elicit a brisk walking intensity. The metabolic heat production test is a standard procedure used in the thermal physiology literature to perform an unbiased comparison of thermoregulatory responses between groups (Jay \& Cramer 2015).
Visit 3 and 4: Experimental Trials (HOT \& TEMP). Experimental trials (HOT and TEMP) will consist of a 60 min treadmill exercise protocol at a fixed metabolic heat production per unit body mass (8 W/kg). Exercise will be performed in an environmental chamber. HR, mean skin temperature (Tsk), core temperature (Tcore), sweat loss, and fluid intake will be measured throughout the exercise protocol. Breast milk composition will be measured through milk expression using a manual expression breast pump 24-hour before (post exercise), one hour-post exercise and 24 hours post-exercise. Breastmilk samples will not be collected at the laboratory. Participants will be asked to collect samples at home and will be provided written instructions on the breastmilk collection procedure (described below). Participants will log their breast milk production for 24 hours before and after the exercise protocol using a supplied infant scale.
Over 24 hr before the start of exercise, participants will be provided with a water bottle to track their fluid intake, Tcore pill, food log, an infant scale, breastmilk production log, manual breastmilk expression pump, storage bag, and small cooler bag for transport. Participants will log their food and fluid intake during the day before, during, and after each experimental trial (24 hr before and after). Participants will be asked to maintain similar dietary habits during either experimental session. Participants will also be given an ingestible pill thermistor for Tcore assessment and asked to consume one pill approximately 6 hours before the start of exercise. Twenty-four hours before the start of the trial, participants will be asked to manually express 5 mL of breast milk immediately before the infant is put on the breast and 5 mL immediately after the infant has finished suckling. Participants who only express breastmilk will collect 5 mL from the start and end of their breastmilk expression session. This will collect fore and hind breast milk samples to account for different lipid concentrations between milk types. The fore and hind breastmilk samples will be analyzed separately and entered into a formula to estimate energy density [2,3] Breastmilk samples will be stored in the breastmilk storage bag provided. Participants will be asked to store the breast milk in their refrigerator and use the provided cooler bag to transport breastmilk when arriving for their visit. Participants will be asked to log breastmilk production by weighing infants (test weighing) or the quantity of expressed breast milk (see weighing infant protocol below).
On the experimental trial days, participants will report to the laboratory in the morning. Hydration status will be assessed through urine-specific gravity, urine color assessment, and body mass changes. If the core temperature pill passes before visit, the participant will have the option to use a core temperature pill as a suppository or re-schedule their trial. The pill will be given to you at your initial visit. Participants will be asked to wear an HR monitor and four skin temperature sensors placed on their chest, shoulder, thigh, and calf to assess mean Tsk. Participants will enter the environmental chamber for the exercise protocol. Immediately upon entering the environmental chamber, participants will perform a seated 10-minute passive equilibration period. Participants will then walk briskly at 8 W/kg for 60 mins. During exercise, Tcore, Tsk, and HR will be continuously monitored. Fluid will not be permitted during exercise.
After completing the exercise protocol, participants will provide a urine sample for hydration assessment, and body mass will be measured. Participants will receive a water bottle to track their fluid intake, food log, an infant scale (Doran DS4500), breastmilk production log, manual breastmilk expression pump, storage bag, and small cooler bag for transport before leaving the laboratory. Participants will be asked to log breastmilk production by weighing infants (test weighing) or the quantity of expressed breast milk. To account for evaporative losses, participants will be asked to measure their infants immediately before (Wb), immediately after (Wa), and 20 min (We) after feeding [4]. One hour and 24 hours after the completion of the exercise, participants will be asked to provide breast milk samples. Participants will be asked to store the breast milk in their refridgerator and use the provided cooler bag to transport breastmilk when arriving for their last visit (Visit 3). Following Visit 3, researchers will ask participants to report to the laboratory with frozen breast milk storage and to return other supplies (i.e., infant scale, manual breastmilk expression pump).
When participants bring in their breastmilk samples, fat content within them will be assessed immediately using the Creamatocrit method (Miller et al. 2013). Three mL of each sample will be aliquoted into separate 1-mL creamatocrit collection tubes. Each 1-mL milk sample will be placed into a micro-capillary tube and centrifuged for 3-5 minutes around 10,000 rpm. The height of the fat layer and total milk column will be measured following centrifugation
The remaining breastmilk sample will be immediately frozen in -80C after collection [5].The protein content of breastmilk samples will be determined using a Pierce Modified Lowry Protein assay kit [5,6] and lactose content will be measured using a lactose colorimetric assay kit after data collection is complete [5,7].
References:
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Heat exposure in environmental chamber during exercise (60 mins)
Other: Heat exposure
Thermoneutral temperature (non-heat exposure condition)
Heat exposure during exercise
Breastmilk Composition
Breastmilk lipid, protein, and lactose content
Time frame: Measured 24hr before exercise, one hour post-exercise, and 24hr post exercise for each condition
Breastmilk Production
Breastmilk production (lactation)
Time frame: Collected 24-hour before exercise, 1-hour post-exercise, and 24-hour post-exercise
Core temperature
Internal core body temperature
Time frame: Collected every minute for 60 minutes during exercise
Heart rate
Heart rate
Time frame: Collected every minute for 60 minutes during exercise
Skin temperature
Mean skin temperature
Time frame: Collected every minute for 60 min during exercise
Plan to share: Yes — Data to be shared upon request.
Supporting information: Study protocol, Statistical analysis plan, Informed consent form
Time frame: Data will be shared following the completion of the study.
Start is estimated for Jul 2025; primary completion for May 2026, 9 months later.
Of 505 non-industry interventional studies with no phase under Breast Feeding, half reached primary completion within 12 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 9 months is below that.
Counting every sponsor, half of 513 studies reached it within 12 months; a quarter within 6 and three quarters within 23.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Providence College